Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 3, 2010, Pages 318-325

  Hirmerova, J ^a   Ulcova Gallova, Z ^a   Seidlerova, J ^a   Filipovsky, J ^a   Bibkova, K ^a   Micanova, Z ^a   Mayer Jr , O ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antiphosphatidylethanolamine antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Prevalence; Venous thromboembolism

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHATIDIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIGENS; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 77953635072     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608331228     Document Type: Article

References (44)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002 ; 346: 752-763.
2. Girolami A., Simioni P., Scarano L., Girolami B. Venous and arterial thrombophilia. Haematologica. 1997 ; 82: 96-100.
3. Triplett DA Antiphospholipid antibodies. Arch Pathol Lab Med. 2002 ; 126: 1424-1429.
4. Galli M. Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol Haemost Thromb. 2003 / 2004 ; 33: 249-255.
5. Triplett DA Antiphospholipid antibodies, lupus anticoagulants and thromboembolic disease. Haematologica. 1995 ; 80 (suppl 2). 122-126.
6. Wilson WA, Gharavi AE, Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999 ; 42: 1309-1311.
7. Schulman S., Svenungsson E., Granvist S., and the Duration of Anticoagulant Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med. 1998 ; 104: 332-338.
8. Casais P., Alberto MF, Gennari LC, Grosso SH, Meschengieser SS, Lazzari MA Anticoagulation in the antiphospholipid syndrome. Haematologica. 2004 ; 89: 503-504.
9. Finazzi G. for the members of the registry. The Italian Registry of Antiphospholipid Antibodies. Haematologica. 1997 ; 82: 101-105.
10. Brandt JT, Triplett DA, Alving B., Scharrer I. Criteria for the diagnosis of lupus anticoagulans: an update. Thromb Haemost. 1995 ; 74: 1185-1190.
11. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006 ; 4: 295-306.
12. Wisløff F., Jacobsen EM, Liestøl S. Laboratory diagnosis of the antiphospholipid syndrome. Thromb Res. 2003 ; 108: 263-271.
13. Carreras LO, Forastiero RR, Martinuzzo ME Which are the best biological markers of the antiphospholipid syndrome ? J Autoimmun. 2000 ; 15: 163-172.
14. Bick RL Hereditary and acquired thrombophilic disorders. Clin Appl Thromb Hemost. 2006 ; 12: 125-135.
15. Bick RL Antiphospholipid thrombosis syndromes. Clin Appl Thromb Hemost. 2001 ; 7: 241-258.
16. Musial J., Swadzba J., Motyl A., Iwaniec T. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. J Rheumatol. 2003 ; 30: 723-730.
17. Lopez LR, Dier KJ, Lopez D., Merrill JT, Fink CA Antiβ2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol. 2004 ; 121: 142-149.
18. Amoroso A., Mitterhofer AP, Del Porto F., et al. Antibodies to anionic phospholipids and anti-β2-GPI: Association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Hum Immunol. 2003 ; 64: 265-273.
19. Ulcova-Gallova Z., Krauz V., Novakova P., et al. Antiphospholipid pntibodies against phosphatidylinositol, and phosphatidylserine are more significant in reproductive failure than antibodies against cardiolipin only. Amer J Reprod Immunol. 2005 ; 54: s112 - s117.
20. Ulcova-Gallova Z. Antiphospholipid antibodies and reproductive failure. Chem Immunol Allergy. 2005 ; 88: 139-149.
21. Mayer O. Jr, Simon J., Hrbková J., Pikner R., Topolcan O. Epidemiological study of hypothyroidism as cardiovascular risk in population. Cas Lek Cesk. 2005 ; 144: 459-464.
22. Arnout J., Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost. 2003 ; 1: 931-942.
23. Galli M., Luciani D., Bertolini G., Barbui T. Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003 ; 102: 2717-2723.
24. Micheloud D., Sánchez-Ramón S., Carbone J., et al. Discordance between anti-beta2-glycoprotein-I and anticardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome. Clin Exp Rheumatol. 2005 ; 23: 525-528.
25. Lee EY, Lee CK, Lee TH, et al. Does the anti-β2-glycoprotein I antibody provide additional information in patients with thrombosis ? Thromb Res. 2003 ; 111: 29-32.
26. Nash MJ, Camilleri RS, Kunka S., Mackie IJ, Machin SJ, Cohen H. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost. 2004 ; 2: 1077-1081.
27. Lackner KJ, Peetz D., von Landenberg P. Revision of the Sapporo criteria for the antiphospholipid syndrome- Coming to grips with evidence and Thomas Bayes ? Thromb Haemost. 2006 ; 95: 917-919.
28. Galli M., Borrelli G., Jacobsen EM, et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood. 2007 ; 110: 1178-1183.
29. Galli M., Reber G., de Moerloose P., de Groot PG Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost. 2008 ; 6: 399-401.
30. Falcón CR, Hoffer AM, Forastiero RM, Carreras LO Antiphosphatidylinositol antibodies as markers of the antiphospholipid syndrome. Thromb Haemost. 1990 ; 63: 321-322.
31. Toschi V., Motta A., Castelli C., Paracchini ML, Zerbi D., Gibelli A. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke. 1998 ; 29: 1759-1764.
32. López-Soto A., Cervera R., Font J., et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus; prospective analysis of a series of 92 patients. Clin Exp Rheumatol. 1997 ; 15: 143-149.
33. Bertolaccini ML, Roch B., Amengual O., Atsumi T., Khamashta MA, Hughes GR Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol. 1998 ; 37: 1229-1232.
34. Berard M., Chantome R., Marcelli A., Boffa MC Antiphoshatidylethanolamine antibodies as the only antiphospholipid entibodies. I. Association with thrombosis and vascular cutaneous diseases. J Rheumatol. 1996 ; 23: 1369.
35. Desauw C., Hachulla E., Boumbar Y., et al. Antiphosphatidylethanolamine antibodies as the sole antiphospholipid antibody: about 20 cases. Rev Méd Interne. 2002 ; 23: 357-363.
36. Sanmarco M., Alessi MC, Harle JR, et al. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb Haemost. 2001 ; 85: 800-805.
37. Sanmarco M., Gayet S., Alessi MC, et al. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. Thromb Haemost. 2007 ; 97: 949-954.
38. Karmochkine M., Berard M., Piette JC, et al. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus. 1993 ; 2: 157-160. (Pubitemid 23225631)
39. Sugi T., McIntyre JA Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood. 1995 ; 86: 3083-3089.
40. Sugi T., McIntyre JA Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies. Thromb Haemost. 1996 ; 76: 354-360.
41. Katsunuma J., Sugi T., Inomo A., Matsubayashi H., Izumi SI, Makino T. Kininogen domain 3 contains regions recognized by antiphosphatidylethanolamine antibodies. J Thromb Haemost. 2003 ; 1: 132-138.
42. Galli M., Luciani D., Bertolini G., Barbui T. Lupus anticoagulants are stronger risk factor of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003 ; 101: 1827-1832.
43. Teruya J., West AG, Suell MN Lupus anticoagulant assays. Questions answered and to be answered. Arch Pathol Lab Med. 2007 ; 131: 885-889.
44. Garcia DA, Khamashta MA, Crowther MA How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Blood. 2007 ; 110: 3122-3127.